MAP3K7 antibody (AA 138-187)
Quick Overview for MAP3K7 antibody (AA 138-187) (ABIN2884735)
Target
See all MAP3K7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 138-187
-
Specificity
- Tak1 antibody detects endogenous levels of Tak1.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human Tak1 (aa138-187).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C.
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Alternative Name
- MAP3K7 / TAK1
-
Background
-
Name/Gene ID: MAP3K7
Subfamily: MLK(MAP3K)
Family: Protein Kinase
Synonyms: MAP3K7, MEKK7, TGF-beta activated kinase 1, TGF1a, TAK1, TGF-beta-activated kinase 1 -
Gene ID
- 6885
-
UniProt
- O43318
-
Pathways
- NF-kappaB Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-